These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30928247)

  • 21. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
    BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.
    Park HS; Lee A; Chae BJ; Bae JS; Song BJ; Jung SS
    J Surg Oncol; 2014 Dec; 110(7):807-12. PubMed ID: 25111682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RANKL induces beige adipocyte differentiation in preadipocytes.
    Matsuo FS; Cavalcanti de Araújo PH; Mota RF; Carvalho AJR; Santos de Queiroz M; Baldo de Almeida B; Ferreira KCOS; Metzner RJM; Ferrari GD; Alberici LC; Osako MK
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E866-E877. PubMed ID: 32315212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the G-Protein-Coupled Receptor 4 in the Increased Expression of RANK/RANKL/OPG System and Neurotrophins by Nucleus Pulposus Cells under the Degenerated Intervertebral Disc-Like Acidic Microenvironment.
    Li H; Liu H; Zhang N; Zhu Z
    Biomed Res Int; 2020; 2020():1328436. PubMed ID: 32566653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of RANKL by biomechanical loading in fibrochondrocytes of meniscus.
    Deschner J; Wypasek E; Ferretti M; Rath B; Anghelina M; Agarwal S
    J Biomech; 2006; 39(10):1796-803. PubMed ID: 16038916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
    Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing.
    Wilson SE; Mohan RR; Netto M; Perez V; Possin D; Huang J; Kwon R; Alekseev A; Rodriguez-Perez JP
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2201-11. PubMed ID: 15223796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
    Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
    J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
    Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
    Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling.
    Ding Z; Shi H; Yang W
    Pharmacology; 2019; 103(3-4):163-172. PubMed ID: 30695776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of RANKL/RANK/OPG system in the canine model of hip periprosthetic infection osteolysis.
    Zhang HW; Peng L; Li WB; Song KG
    Int J Artif Organs; 2017 Feb; 39(12):619-624. PubMed ID: 28127738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genomic approaches to bone and joint diseases. Mutations of RANK, OPG and RANKL genes found in humans].
    Kobayashi Y; Takahashi N
    Clin Calcium; 2008 Feb; 18(2):202-9. PubMed ID: 18245890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.
    Peng WX; Ye C; Dong WT; Yang LL; Wang CQ; Wei ZA; Wu JH; Li Q; Deng J; Zhang J
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1234-1243. PubMed ID: 28454497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized Titanium Implants Enhance Osseointegration via Mechanisms Involving RANK/RANKL/OPG Regulation.
    Lennerås M; Palmquist A; Norlindh B; Emanuelsson L; Thomsen P; Omar O
    Clin Implant Dent Relat Res; 2015 Oct; 17 Suppl 2():e486-500. PubMed ID: 25536123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
    Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
    Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension.
    Yang J; Si D; Zhao Y; He C; Yang P
    Biomed Pharmacother; 2019 Jun; 114():108799. PubMed ID: 30951948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases.
    Baud'huin M; Lamoureux F; Duplomb L; Rédini F; Heymann D
    Cell Mol Life Sci; 2007 Sep; 64(18):2334-50. PubMed ID: 17530461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG.
    Aoyama E; Kubota S; Khattab HM; Nishida T; Takigawa M
    Bone; 2015 Apr; 73():242-8. PubMed ID: 25554597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology.
    Melchiorre D; Milia AF; Linari S; Romano E; Benelli G; Manetti M; Guiducci S; Ceccarelli C; Innocenti M; Carulli C; Civinini R; Morfini M; Matucci-Cerinic M; Ibba-Manneschi L
    J Rheumatol; 2012 Aug; 39(8):1678-86. PubMed ID: 22753650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.